Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

887 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors.
Merchant MS, Geller JI, Baird K, Chou AJ, Galli S, Charles A, Amaoko M, Rhee EH, Price A, Wexler LH, Meyers PA, Widemann BC, Tsokos M, Mackall CL. Merchant MS, et al. Among authors: galli s. J Clin Oncol. 2012 Nov 20;30(33):4141-7. doi: 10.1200/JCO.2012.44.1055. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071222 Free PMC article. Clinical Trial.
Biomarkers in the age of omics: time for a systems biology approach.
Abu-Asab MS, Chaouchi M, Alesci S, Galli S, Laassri M, Cheema AK, Atouf F, VanMeter J, Amri H. Abu-Asab MS, et al. Among authors: galli s. OMICS. 2011 Mar;15(3):105-12. doi: 10.1089/omi.2010.0023. Epub 2011 Feb 14. OMICS. 2011. PMID: 21319991 Free PMC article.
Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
Czarnecka M, Trinh E, Lu C, Kuan-Celarier A, Galli S, Hong SH, Tilan JU, Talisman N, Izycka-Swieszewska E, Tsuei J, Yang C, Martin S, Horton M, Christian D, Everhart L, Maheswaran I, Kitlinska J. Czarnecka M, et al. Among authors: galli s. Oncogene. 2015 Jun 11;34(24):3131-43. doi: 10.1038/onc.2014.253. Epub 2014 Aug 18. Oncogene. 2015. PMID: 25132261 Free PMC article.
Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
Galli S, Naranjo A, Van Ryn C, Tilan JU, Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, Lee YC, Rodriguez OC, Albanese C, Kitlinska J. Galli S, et al. Am J Pathol. 2016 Nov;186(11):3040-3053. doi: 10.1016/j.ajpath.2016.07.019. Epub 2016 Oct 12. Am J Pathol. 2016. PMID: 27743558 Free PMC article.
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
Tilan JU, Krailo M, Barkauskas DA, Galli S, Mtaweh H, Long J, Wang H, Hawkins K, Lu C, Jeha D, Izycka-Swieszewska E, Lawlor ER, Toretsky JA, Kitlinska JB. Tilan JU, et al. Among authors: galli s. Cancer. 2015 Mar 1;121(5):697-707. doi: 10.1002/cncr.29090. Epub 2014 Nov 11. Cancer. 2015. PMID: 25387699 Free PMC article.
Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.
Lu C, Mahajan A, Hong SH, Galli S, Zhu S, Tilan JU, Abualsaud N, Adnani M, Chung S, Elmansy N, Rodgers J, Rodriguez O, Albanese C, Wang H, Regan M, Zgonc V, Blancato J, Krawczyk E, Gallicano GI, Girgis M, Cheema A, Iżycka-Świeszewska E, Cavalli LR, Pack SD, Kitlinska J. Lu C, et al. Among authors: galli s. Nat Commun. 2022 Apr 28;13(1):2323. doi: 10.1038/s41467-022-29898-x. Nat Commun. 2022. PMID: 35484119 Free PMC article.
Publisher Correction: Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.
Lu C, Mahajan A, Hong SH, Galli S, Zhu S, Tilan JU, Abualsaud N, Adnani M, Chung S, Elmansy N, Rodgers J, Rodriguez O, Albanese C, Wang H, Regan M, Zgonc V, Blancato J, Krawczyk E, Gallicano GI, Girgis M, Cheema A, Iżycka-Świeszewska E, Cavalli LR, Pack SD, Kitlinska J. Lu C, et al. Among authors: galli s. Nat Commun. 2022 May 12;13(1):2729. doi: 10.1038/s41467-022-30473-7. Nat Commun. 2022. PMID: 35550518 Free PMC article. No abstract available.
887 results